BrainAurora Medical Technology Limited (HKG:6681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.190
+0.010 (0.24%)
Apr 16, 2026, 4:08 PM HKT

HKG:6681 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
220.05122.3167.211.292.3
Revenue Growth (YoY)
79.91%82.01%495.16%391.13%-
Cost of Revenue
130.668.335.147.991
Gross Profit
89.4554.0132.063.31.3
Selling, General & Admin
175.58107.9487.2739.6937.6
Research & Development
165.9119.4290.7367.6332.76
Operating Expenses
380.41238.85178.85107.3770.37
Operating Income
-290.95-184.83-146.78-104.07-69.06
Interest Expense
-23.99-22.03-20.22-19.22-6.39
Interest & Investment Income
13.650.632.083.91.33
Currency Exchange Gain (Loss)
-8.83-0.33-0.07--
Other Non Operating Income (Expenses)
-3.06-22.11-25.77-0.290.05
EBT Excluding Unusual Items
-313.18-228.67-190.76-119.68-74.08
Merger & Restructuring Charges
---5.53--
Gain (Loss) on Sale of Investments
1.1230.12-162.54-382.65-623.76
Gain (Loss) on Sale of Assets
-0.060-0.06-0.130.01
Other Unusual Items
-4.14-0.01-0.22--
Pretax Income
-316.26-198.56-359.12-502.46-697.84
Income Tax Expense
0.10.05---
Earnings From Continuing Operations
-316.36-198.61-359.12-502.46-697.84
Minority Interest in Earnings
1.50.330.030.010
Net Income
-314.86-198.28-359.08-502.45-697.84
Net Income to Common
-314.86-198.28-359.08-502.45-697.84
Shares Outstanding (Basic)
1,176904584281150
Shares Outstanding (Diluted)
1,1761,000584281150
Shares Change (YoY)
17.58%71.29%108.01%86.78%-
EPS (Basic)
-0.27-0.22-0.62-1.79-4.64
EPS (Diluted)
-0.27-0.23-0.62-1.79-4.64
Free Cash Flow
--163.37-152.84-117.08-60.01
Free Cash Flow Per Share
--0.16-0.26-0.42-0.40
Gross Margin
40.65%44.16%47.71%29.20%56.72%
Operating Margin
-132.22%-151.12%-218.43%-921.71%-3004.09%
Profit Margin
-143.09%-162.11%-534.35%-4450.02%-30353.94%
Free Cash Flow Margin
--133.57%-227.44%-1036.94%-2610.05%
EBITDA
-273.41-167.29-132.78-98.34-68.45
EBITDA Margin
-124.25%-136.77%-197.59%--
D&A For EBITDA
17.5517.5514.015.730.61
EBIT
-290.95-184.83-146.78-104.07-69.06
EBIT Margin
-132.22%-151.12%-218.43%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.